Skip to main content
Log in

Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction/objectives

Asian scores developed to predict unresponsiveness to intravenous immunoglobulin (IVIG) or development of coronary artery aneurysms (CAA) in patients with Kawasaki disease (KD) are not appropriate in Western populations. The purpose of this study is to develop 2 scores, to predict unresponsiveness to IVIG and development of CAA, appropriate for Spanish population.

Method

Data of 625 Spanish children with KD collected retrospectively (2011–2016) were used to identify variables to develop the 2 scores of interest: unresponsiveness to IVIG and development of CAA. A statistical model selected best variables to create the scores, and scores were validated with data from 98 patients collected prospectively.

Results

From 625 patients of the retrospective cohort, final analysis was performed in 439 subjects: 37 developed CAA, and 212 were unresponsive to IVIG. For the score to predict CAA, a cutoff ≥ 8 was considered for high risk, considering a score system with a different weight for each of the eight variables. External validation showed a sensitivity of 22% and a specificity of 75%. The score to predict unresponsiveness to IVIG established a cutoff ≥ 8 for high risk, considering a score system with a different weight for each of the nine variables. External validation showed a sensitivity of 78% and a specificity of 50%.

Conclusions

Two risk scores for KD were developed from Spanish population, to predict development of CAA and unresponsiveness to IVIG; validation in other cohorts could help to implement these tools in the management of KD in other Western populations.

Key Points

• Two risk scores for KD were developed from Spanish population, to predict development of CAA and unresponsiveness to IVIG.

• External validation of the score to predict development of CAA showed a sensitivity of 22% and a specificity of 75%.

• External validation of the score to predict unresponsiveness to IVIG showed a sensitivity of 78% and a specificity of 50%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. McCrindle BW, Rowley AH, Newburger JW et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999. https://doi.org/10.1161/CIR.0000000000000484

    Article  PubMed  Google Scholar 

  2. Newburger JW, Takahashi M, Burns JC et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341–347. https://doi.org/10.1056/nejm198608073150601

    Article  CAS  PubMed  Google Scholar 

  3. Mori M, Miyamae T, Imagawa T et al (2004) Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease. Mod Rheumatol 14:361–366. https://doi.org/10.1007/s10165-004-0324-3

    Article  CAS  PubMed  Google Scholar 

  4. Davies S, Sutton N, Blackstock S et al (2015) Predicting IVIG resistance in UK Kawasaki disease. Arch Dis Child 100:366–368. https://doi.org/10.1136/archdischild-2014-307397

    Article  PubMed  Google Scholar 

  5. Egami K, Muta H, Ishii M et al (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237–240. https://doi.org/10.1016/j.jpeds.2006.03.050

    Article  CAS  PubMed  Google Scholar 

  6. Kobayashi T, Inoue Y, Takeuchi K et al (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606–2612. https://doi.org/10.1161/CIRCULATIONAHA.105.592865

    Article  PubMed  Google Scholar 

  7. Sano T, Kurotobi S, Matsuzaki K et al (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131–137. https://doi.org/10.1007/s00431-006-0223-z

    Article  CAS  PubMed  Google Scholar 

  8. Ae R, Makino N, Kosami K et al (2020) Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017-2018. J Pediatr 225:23–29.e2. https://doi.org/10.1016/j.jpeds.2020.05.034

    Article  PubMed  Google Scholar 

  9. Tulloh RMR, Mayon-White R, Harnden A et al (2019) Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015. Arch Dis Child 104:640–646. https://doi.org/10.1136/archdischild-2018-315087

    Article  PubMed  Google Scholar 

  10. Sanchez-Manubens J, Anton J, Prada F et al (2014) Incidence and clinical features of Kawasaki disease in Catalonia (Spain). Pediatr Rheumatol 12:P123. https://doi.org/10.1186/1546-0096-12-s1-p123

    Article  Google Scholar 

  11. Fernandez-Cooke E, Tascón AB, Sánchez-Manubens J et al (2019) Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011- 2016): KAWA-RACE study group. PLoS One 14

  12. Piram M, Darce Bello M, Tellier S et al (2020) Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease. Sci Rep 10. https://doi.org/10.1038/s41598-020-59972-7

  13. Sleeper LA, Minich LL, BM MC et al (2011) Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 158:831–835.e3. https://doi.org/10.1016/j.jpeds.2010.10.031

    Article  PubMed  Google Scholar 

  14. Fabi M, Andreozzi L, Corinaldesi E et al (2019) Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort. Eur J Pediatr 178:315–322. https://doi.org/10.1007/s00431-018-3297-5

    Article  CAS  PubMed  Google Scholar 

  15. Kaya Akca U, Arslanoglu Aydin E, Aykan HH et al (2021) Comparison of IVIG resistance predictive models in Kawasaki disease. Pediatr Res. https://doi.org/10.1038/S41390-021-01459-W

  16. Tremoulet AH, Best BM, Song S et al (2008) Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153:117–121.e3. https://doi.org/10.1016/j.jpeds.2007.12.021

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bar-Meir M, Kalisky I, Schwartz A et al (2018) Prediction of resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr Infect Dis Soc 7:25–29. https://doi.org/10.1093/JPIDS/PIW075

    Article  Google Scholar 

  18. Son MBF, Gauvreau K, Tremoulet AH et al (2019) Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a North American population. J Am Heart Assoc 8. https://doi.org/10.1161/JAHA.118.011319

  19. Miyata K, Miura M, Kaneko T et al (2021) Evaluation of a Kawasaki disease risk model for predicting coronary artery aneurysms in a Japanese population: an analysis of post RAISE. J Pediatr 237:96–101.e3. https://doi.org/10.1016/j.jpeds.2021.06.022

    Article  PubMed  Google Scholar 

  20. Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747–2771

    Article  PubMed  Google Scholar 

  21. Stekhoven DJ, Bühlmann P (2012) Missforest-Non-parametric missing value imputation for mixed-type data. Bioinformatics 28:112–118. https://doi.org/10.1093/bioinformatics/btr597

    Article  CAS  PubMed  Google Scholar 

  22. Zhang Z, Zhang H, Khanal MK (2017) Development of scoring system for risk stratification in clinical medicine: a step-by-step tutorial. Ann Transl Med 5:19–19. https://doi.org/10.21037/atm.2017.08.22

    Article  Google Scholar 

  23. Thiele C, Hirschfeld G (2021) Cutpointr: Improved estimation and validation of optimal cutpoints in r. J Stat Softw 98. https://doi.org/10.18637/jss.v098.i11

  24. Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33:1–22. https://doi.org/10.18637/JSS.V033.I01

    Article  PubMed  PubMed Central  Google Scholar 

  25. Sánchez-Manubens J, Antón J, Bou R et al (2016) Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population. Rheumatol Int 36:905–910. https://doi.org/10.1007/s00296-016-3499-y

    Article  CAS  PubMed  Google Scholar 

  26. Heuclin T, Dubos F, Hue V et al (2009) Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography. J Pediatr 155. https://doi.org/10.1016/J.JPEDS.2009.04.058

  27. Kobayashi T, Saji T, Otani T et al (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379:1613–1620. https://doi.org/10.1016/S0140-6736(11)61930-2

    Article  CAS  PubMed  Google Scholar 

  28. Koné-Paut I, Tellier S, Belot A et al (2021) Phase II open label study of anakinra in intravenous immunoglobulin-resistant Kawasaki disease. Arthritis Rheumatol (Hoboken, NJ) 73:151–161. https://doi.org/10.1002/ART.41481

    Article  Google Scholar 

  29. Tremoulet AH, Jain S, Jaggi P et al (2014) Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet 383:1731–1738. https://doi.org/10.1016/S0140-6736(13)62298-9

    Article  CAS  PubMed  Google Scholar 

  30. Burns JC, Roberts SC, Tremoulet AH et al (2021) Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc Health 5:852–861. https://doi.org/10.1016/S2352-4642(21)00270-4/ATTACHMENT/DA6067A7-0422-4199-904F-100060DA2606/MMC1.PDF

    Article  CAS  PubMed  Google Scholar 

  31. Barrios Tascón A, Centeno Malfaz F, Rojo Sombrero H et al (2018) National consensus on the cardiological treatment and follow-up of Kawasaki disease. An Pediatr 89:188.e1–188.e22. https://doi.org/10.1016/j.anpedi.2018.04.003

    Article  Google Scholar 

Download references

Acknowledgements

The KAWA-RACE study group is composed by the following:

Study coordinator: Elisa Fernández-Cooke (Hospital Doce de Octubre, Spain).

Scientific committee: Elisa Fernandez-Cooke (Hospital 12 de Octubre, Madrid), Cristina Calvo (Hospital Universitario La Paz, Madrid), Ana Barrios Tascón (Hospital Universitario Infanta Sofia, Madrid), Judith Sánchez-Manubens (Hospital Sant Joan de Deu, Barcelona), Jordi Antón (Hospital Sant Joan de Deu, Barcelona), Javier Aracil Santos (Hospital Universitario La Paz, Madrid), Esmeralda Nuñez Cuadros (Hospital Regional Universitario de Malaga), Maria Luisa Navarro Gómez (Hospital Universitario Gregorio Marañon, Madrid), David Moreno Pérez (Hospital Regional Universitario de Málaga).

Collaborating members: María Martín Cantero Pérez (Hospital Regional Universitario de Málaga), Esmeralda Nuñez Cuadros Pérez (Hospital Regional Universitario de Málaga), Begoña Carazo Gallego Pérez (Hospital Regional Universitario de Málaga), Fernando Sánchez García (Hospital La Inmaculada, Almería), Marisol Camacho Lovillo (Hospital Virgen del Rocío, Sevilla), Renata Marqués (Hospital Virgen del Rocío, Sevilla), Olaf Neth (Hospital Virgen del Rocío, Sevilla), Laura, Fernández Silveira (Hospital Virgen del Rocío, Sevilla), Miguel Sánchez Forte (Hospital Torrecardenas, Almería), Ángeles Ortega Montes (Hospital Torrecardenas, Almería), Leticia Isabel Martínez Campos (Hospital Torrecardenas, Almería), Beatriz Bravo Mancheño (Hospital Universitario Virgen de las Nieves, Granada), Margarita Camacho (Hospital Universitario Virgen de las Nieves, Granada), Antonio F Medina Claros (Hospital de la Axarquía, Murcia), Carlos Salido (Hospital de Jerez), María Torres Rico (Hospital Juan Ramón Jiménez de Huelva), Beatriz Ruiz Saez (Hospital Reina Sofia de Córdoba), Elena Fernadez de la Puebla Lechuga (Hospital Reina Sofia de Córdoba), Mª José Lirola Cruz (Instituto Hispalense de pediatría, Sevilla), Kety Maya Carrasco (Instituto Hispalense de pediatría, Sevilla), Moisés Rodríguez González (Hospital Universitario Puerta Del Mar de Cádiz), Enrique Blanca Jover (Complejo Hospitalario Granada), José Uberos Fernández (Complejo Hospitalario Granada), María Mercedes Ibáñez Alcalde (Hospital de Poniente, Almería), Miguel Lafuente Hidalgo (Hospital Universitario Miguel Servet, Zaragoza), Lorenzo Jiménez Montañés (Hospital Universitario Miguel Servet, Zaragoza), Matilde Bustillo Alonso (Hospital Universitario Miguel Servet, Zaragoza), Ariadna Ayerza Casas (Hospital Clínico Universitario Lozano Blesa, Zaragoza), Bárbara Montes Zapico (Hospital San Agustín, Avilés), Carlos Pérez Méndez (Hospital Universitario de Cabueñes, Gijón), Javier Fernández Aracama (Hospital Universitario Basurto, Bilbao), Lucía Rodríguez (Hospital Central de Asturias, Oviedo), María Aleida Ibáñez Fernández (Hospital Central de Asturias, Oviedo), Silvia Escribà Bori (Hospital Universitario Son Espases, Palma de Mallorca), María Concepción Mir Perelló (Hospital Universitario Son Espases, Palma de Mallorca), Mª Ángeles de la Fuente Sánchez (Hospital Universitario Son Espases, Palma de Mallorca), Patricia Aparicio García (Hospital Son Llátzer, Palma de Mallorca), Carlos Briales (Hospital Son Llátzer, Palma de Mallorca), Joaquín Castilla Crespí (Hospital Son Llátzer, Palma de Mallorca), María Elena Colino Gil (Hospital Materno-Infantil de Las Palmas de Gran Canaria), Nerea Delgado Cabrera (Hospital Materno-Infantil de Las Palmas de Gran Canaria), Ana Bello Naranjo (Hospital Materno-Infantil de Las Palmas de Gran Canaria), Jesús Poch Páez (Hospital Materno-Infantil de Las Palmas de Gran Canaria), Moneyba García Yáñez (Hospital Materno-Infantil de Las Palmas de Gran Canaria), Montse González García (Hospital Universitario Nuestra señora de Candelaria de Santa Cruz de Tenerife), Maite Viadero (Hospital Universitario Marqués de Valdecilla, Santander), Beatriz Jiménez Montero (Hospital Universitario Marqués de Valdecilla, Santander), Olga Domínguez García (Hospital Virgen de la Salud de Toledo), Begoña Losada Pinedo (Hospital Virgen de la Salud de Toledo), Gema Iñigo Martín (Hospital Virgen de la Salud de Toledo), Lucía María Escribano Gómez (Hospital General de Albacete), Miguel Lillo Lillo (Hospital General de Albacete), María Isabel Buedo (Hospital General de Albacete), Laura del Rey (Hospital General de Albacete), Elena Urbaneja Rodríguez (Hospital Clínico Universitario de Valladolid), Sara Rellán Rodríguez (Hospital Clínico Universitario de Valladolid), Teresa Cantero (Hospital de Palencia), Beatriz Plata Izquierdo (Complejo Asistencial Universitario de Salamanca), Luisa García-Cuenllas Álvarez (Complejo Asistencial Universitario de Salamanca), Ignacio Oulego Erroz (Hospital de León), Elena Pérez Santaolalla (Hospital Universitario de Burgos), Carlos Alcalde Martín (Hospital Universitario Río Hortega de Valladolid), Fernando Centeno Malfaz (Hospital Universitario Río Hortega de Valladolid), Elena Pérez Gutiérrez (Hospital Universitario Río Hortega de Valladolid), Mª Soledad Jiménez Casso (Hospital General de Segovia), Fredy Prada (Hospital Sant Joan de Déu, Barcelona), Rosa Bou (Hospital Sant Joan de Déu, Barcelona), Estibaliz Iglesias (Hospital Sant Joan de Déu, Barcelona), Joan Calzada (Hospital Sant Joan de Déu, Barcelona), Olga Calavia Garsaball (Hospital Joan XXIII de Tarragona), Marc Tobeña Rue (Hospital Vall d’Hebron, Barcelona), Gemma Giralt García (Hospital Vall d’Hebron, Barcelona), Zulema Lobato (Xarxa Assistencial i Universitaria de Manresa), Neus Rius Gordillo (Hospital Sant Joan de Reus), Montserrat Pascual Torres (Hospital Sant Joan de Reus), María Méndez Hernández (Hospital Germans Trias i Pujol de Badalona), Lourdes García (Hospital de Mataró), Sergio Flores Villar (Hospital Universitari Mútua de Terrassa), Silvia Yevenes Ruiz (Hospital Universitari Mútua de Terrassa), Laura Minguell Domingo (Hospital Arnau de Vilanova, Lleida), Anna Ballester (Hospital de Calella), Ana Miralles (Hospital de Palamós), Berta Pujol Soler (Hospital General de Granollers), Anton Foguet Vidal (F. Hospital d’Olot Comarcal de la Garrotxa), Pere Sala Castellví (Hospital de Barcelona), Angelita Serrano Aguiar (Hospital Comarcal Mòra d’Ebre), José Manuel Siurana Rodríguez (Hospital HM Nens. HM Hospitales), Anna Sangorrin Iranzo (Hospital HM Nens. HM Hospitales), Roser Álvarez Pérez (Hospital de la Santa Creu i Sant Pau de Barcelona), Nathalia Joaqui López, Vanessa Laveglia (Hospital General de Catalunya), Ricardo González Amador (Hospital Verge de la Cinta, Tortosa), Ana Grande Tejada (Complejo Hospitalario Universitario Infanta Cristina, Badajoz), Cristina Zarallo (Complejo Hospitalario Universitario Infanta Cristina, Badajoz), Federico Martinón-Torres (Hospital Clínico Universitario de Santiago de Compostela), Irene Rivero Calle (Hospital Clínico Universitario de Santiago de Compostela), Antonio Justicia Grande, (Hospital Clínico Universitario de Santiago de Compostela), María López Sousa (Hospital Clínico Universitario de Santiago de Compostela), Alejandro Souto Vilas (Hospital Clínico Universitario de Santiago de Compostela), Bernardo López Abel (Hospital Clínico Universitario de Santiago de Compostela), Elisa de Miguel Esteban (Hospital San Pedro, Logroño), Bibiana Riaño Méndez (Hospital San Pedro, Logroño), Daniel Blázquez (Hospital Universitario Doce de Octubre, Madrid), Pablo Rojo Conejo (Hospital Universitario Doce de Octubre, Madrid), Carlos Grasa Lozano (Hospital Universitario La Paz, Madrid), Belén Toral (Hospital Universitario Doce de Octubre, Madrid), Leticia Albert De la Torre (Hospital Universitario Doce de Octubre, Madrid), Jaime de Inocencio (Hospital Universitario Doce de Octubre, Madrid), Mar Santos (Hospital Universitario Gregorio Marañon, Madrid), Rafael Díaz-Delgado de la Peña (Hospital Severo Ochoa, Leganés), Paz Collado Ramos (Hospital Severo Ochoa, Leganés), Alfredo Tagarro (Hospital Universitario Infanta Sofia, Madrid), Teresa Raga (Hospital Universitario Infanta Sofia, Madrid), Libertad Latorre (Hospital Universitario Infanta Sofia, Madrid), Sara Guillén (Hospital de Getafe), Ignacio Callejas Caballero (Hospital de Getafe), María Esquivas Asenjo (Hospital de Getafe), Luis Manuel Prieto Tato (Hospital 12 de Octubre), Sandra Villagrá (HM Hospitales Madrid), Viviana Arreo (HM Hospitales Madrid), Roi Piñeiro Pérez (Hospital General de Vilalba), María de la Parte (Hospital General de Villalba), Amalia Tamariz-Martes (Hospital Infantil Universitario Niño Jesús, Madrid), Marta Llorente Romano (Hospital del Sureste, Madrid), Maria Belén Hernández Rupérez (Hospital del Sureste, Madrid), Henar Rojo Sombrero (Hospital Universitario Príncipe de Asturias, Alcalá de Henares), Estefanía García Cerro (Hospital Universitario Príncipe de Asturias, Alcalá de Henares), Irene Maté Cano (Hospital del Henares, Coslada), Marta Villares Alonso (Hospital de Móstoles), Marta Pilar Osuna Marco (Hospital de Móstoles), Julia Jensen Veron (Hospital Infanta Cristina, Madrid), Cristina Zarallo Reales (Hospital Infanta Cristina, Madrid), María Dolores Rodríguez Mesa (Hospital Infanta Cristina, Madrid), Santiago Rueda Esteban (Hospital Clínico San Carlos, Madrid), José Tomás Ramos Amador (Hospital Clínico San Carlos, Madrid), Cristina González Menchén (Hospital Clínico San Carlos, Madrid), Ana Belén Jiménez Jiménez (Hospital Universitario Fundación Jiménez Díaz, Madrid), Pilar Galán (Hospital Universitario de Fuenlabrada), Dolores Pérez Campos (Hospital Universitario de Fuenlabrada), Mª Mercedes Bueno (Fundación Hospital de Alcorcón), David Crespo Marcos (Fundación Hospital de Alcorcón), Enrique Otheo de Tejada Barásoain (Hospital Ramón y Cajal, Madrid), Walter Alberto Sifuentes Giraldo (Hospital Ramón y Cajal, Madrid), María Luz Gámir Gámir (Hospital Ramón y Cajal, Madrid), María José Cilleruelo Ortega (Hospital Puerta de Hierro, Majadahonda), Agustín López López (Hospital Puerta de Hierro, Majadahonda), Cristina Sánchez Vaquerizo (Hospital Puerta de Hierro, Majadahonda), Ana Isabel Usano Carrasco (Hospital Puerta de Hierro, Majadahonda), Ester Moreno Gómez (Hospital San Rafael, Madrid), Olga Carvajal del Castillo (Hospital Rey Juan Carlos, Móstoles), Beatriz Del Pozo Menéndez Hospital de Torrejón), Katie Badillo Navarro (Hospital de Torrejón), Fernando Baquero (Hospital Universitario La Paz, Madrid), Lucía Deiros Bronte (Hospital Universitario La Paz, Madrid), Pablo Fernández Fraga (Hospital Universitario La Paz, Madrid), Nieves Domínguez (Hospital Universitario Infanta Elena, Madrid), Beatriz Mercader Rodríguez (Hospital Clínico Universitario Virgen de la Arrixaca, Murcia), Francisco Castro García (Hospital Clínico Universitario Virgen de la Arrixaca, Murcia), Águeda Herrera Chamorro (Hospital Clínico Universitario Virgen de la Arrixaca, Murcia), Paula Alcañiz Rodríguez (Hospital Clínico Universitario Virgen de la Arrixaca, Murcia), Moisés Sorlí García (Hospital Clínico Universitario Virgen de la Arrixaca, Murcia), María Concepción Rex Nicolás (Hospital Universitario Santa Lucía, Cartagena), Elena Vera Romero (Hospital Universitario Santa Lucía, Cartagena), Patricia Martínez Olorón (Complejo Hospitalario de Navarra), Beatriz Rocandio Cilveti (Hospital de Donostia), Amaia Berridi (Hospital de Donostia), Laura Santos-Díez Vázquez (Hospital de Cruces, Bilbao), Olaia Fernández (Hospital Universitario Basurto, Bilbao), Inmaculada Calvo (Hospital Universitario y Politécnico La Fe, Valencia), Belén Fernández Tudela (Hospital Universitario y Politécnico La Fe, Valencia), Manuel Oltra Benavent (Hospital Universitario y Politécnico La Fe, Valencia), Marta Dapena Archilés (Hospital General de Castellón), Franciasco Sanchez Ferrer (Hospital Universitario de San Juan de Alicante), César Gavilán (Hospital Universitario de San Juan de Alicante), Ignacio Izquierdo Fos (Hospital Universitario de Elche), María Isabel Serrano Robles (Hospital Universitario de Elche), Yolanda Herranz Sánchez (Hospital Marina Baixa de Alicante), Enrique Villalobos Pinto (Hospital Infantil Universitario Niño Jesús, Madrid), Daniel Clemente Garulo (Hospital Infantil Universitario Niño Jesús, Madrid), Stella Pie (Hospital Universitari Doctor Josep Trueta, Girona), Manuel Marrero Calvo (Hospital Nuestra Señora de Sonsoles, Ávila), José María Olmos García (Hospital Mare de Déu dels Lliris, de Alcoy, Alicante).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Elisa Fernández-Cooke.

Ethics declarations

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 311 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grasa, C.D., Fernández-Cooke, E., Domínguez-Rodríguez, S. et al. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort. Clin Rheumatol 41, 3759–3768 (2022). https://doi.org/10.1007/s10067-022-06319-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-022-06319-4

Keywords

Navigation